October 12, 2017 — According to a recent survey, participation in bundled payments has improved the quality of care, and ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
October 12, 2017
October 11, 2017 — An analysis of more than 1,000 minimally invasive aortic valve replacements and more than 400 ...
October 11, 2017
October 9, 2017 — The U.S. Food and Drug Administration (FDA) is evaluating recent information regarding Type IIIa and ...
October 09, 2017
October 5, 2017 — BTG plc announced it has acquired Roxwood Medical, provider of advanced cardiovascular specialty ...
October 05, 2017
Feature | Cardiovascular Information Systems (CVIS) | Dave Fornell
Consolidation of data in one location to improve efficiency and enable data analytics, as well as smooth integration ...
October 04, 2017
October 4, 2017 — Medtronic received U.S. Food and Drug Administration (FDA) approval for its HeartWare HVAD System as a ...
October 04, 2017
October 3, 2017 — Despite expectations to the contrary, a new survey from cardiovascular healthcare consulting firm ...
October 03, 2017October 2, 2017 — Cardiovascular healthcare membership organization and performance community MedAxiom announced its ...
October 02, 2017
October 2, 2017 — Medtronic recently announced a new post-market clinical study to evaluate its CoreValve Evolut Pro ...
October 02, 2017
September 28, 2017 — Abiomed Inc. recently received U.S. Food and Drug Administration (FDA) pre-market approval (PMA) ...
September 28, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of implantable cardioverter defibrillator ...
September 27, 2017
September 27, 2017 — Toshiba Medical announced it will highlight several of its latest vascular and interventional ...
September 27, 2017
September 26, 2017 — BioCardia Inc. recently announced 12-month results from the Phase II TRIDENT clinical trial ...
September 26, 2017September 26, 2017 — The one-year results of the SENTRY clinical trial were presented by principal investigator Michael ...
September 26, 2017
September 25, 2017 — BioCardia Inc. announced the trial design for its pivotal Phase III CardiAMP Heart Failure Trial ...
September 25, 2017